COVID-19 Treatment Clinic

at CHA Everett Hospital

CHA offers COVID-19 treatments using antiviral medications and monoclonal antibodies.

When used early, these therapies can help treat mild-to-moderate COVID-19 in high-risk patients.

How to Get Connected to Care

There are several ways to access these treatments: 

  • Your CHA provider can place a referral for you
  • You can self-refer by calling us at 781-338-0280
  • A non-CHA provider can make a referral for you by completing our Google form or by downloading and faxing a referral form (978-367-9946).
Online Referrals (Google form)

Download and fax: Evusheld (PDF)

Download and fax: Bebtelovimab and Remdesivir (PDF)

Available Treatments

PAXLOVID and Molnupiravir are oral medications (by mouth) that may be given within 5 days of symptom onset.

Remdesivir (VEKLURY) is an intravenous (IV) antiviral medication which requires infusion on 3 consecutive days and must be started within 7 days of symptom onset.

Bebtelovimab is a monoclonal antibody treatment that is given as a single intravenous (IV) injection within 7 days of symptom onset.

Use of monoclonal antibodies or antiviral medications is not a substitute for vaccination against COVID-19.
Everyone is still encouraged to get vaccinated as soon as they can, whether it is a first, second or booster dose.

Conditions We Treat


Affiliated with:
Teaching hospital of: